News & Events :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Recent NewsView All News

Oct 5, 2022 8:00am EDT

Alzamend Neuro Announces Addition of Healthy Subjects to Ongoing Phase IIA Clinical Trial for AL001 in Alzheimer’s Subjects

Sep 29, 2022 8:00am EDT

Alzamend Neuro Submits IND Application for Phase I/IIA Trial for an Immunotherapy (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type

Latest Presentation View All Presentations

Alzamend - Corporate Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Subscribe to Our Newsletter

Making Alzheimer’s
Just a Memory^™

About

Investor Relations

Other